KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
Europe - Euronext Amsterdam - AMS:PHIA - NL0000009538 - Common Stock
25.62 EUR
+0.19 (+0.75%)
Overall PHIA gets a fundamental rating of 3 out of 10. We evaluated PHIA against 68 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHIA have multiple concerns. PHIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
PHIA had positive earnings in the past year.
PHIA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
Of the past 5 years PHIA 4 years had a positive operating cash flow.
1.2 Ratios
PHIA's Return On Assets of 0.63% is on the low side compared to the rest of the industry. PHIA is outperformed by 64.71% of its industry peers.
PHIA has a Return On Equity of 1.56%. This is in the lower half of the industry: PHIA underperforms 64.71% of its industry peers.
PHIA has a worse Return On Invested Capital (4.21%) than 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.63% | ||
| ROE | 1.56% | ||
| ROIC | 4.21% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA has a worse Profit Margin (0.93%) than 64.71% of its industry peers.
Looking at the Operating Margin, with a value of 6.10%, PHIA is doing worse than 60.29% of the companies in the same industry.
PHIA's Operating Margin has declined in the last couple of years.
PHIA's Gross Margin of 43.49% is on the low side compared to the rest of the industry. PHIA is outperformed by 75.00% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.1% | ||
| PM (TTM) | 0.93% | ||
| GM | 43.49% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHIA is destroying value.
PHIA has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PHIA has more shares outstanding
The debt/assets ratio for PHIA is higher compared to a year ago.
2.2 Solvency
PHIA has an Altman-Z score of 2.01. This is not the best score and indicates that PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
PHIA has a Altman-Z score of 2.01. This is comparable to the rest of the industry: PHIA outperforms 42.65% of its industry peers.
The Debt to FCF ratio of PHIA is 14.51, which is on the high side as it means it would take PHIA, 14.51 years of fcf income to pay off all of its debts.
PHIA has a worse Debt to FCF ratio (14.51) than 60.29% of its industry peers.
PHIA has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
PHIA's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. PHIA is outperformed by 72.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 14.51 | ||
| Altman-Z | 2.01 |
ROIC/WACC0.67
WACC6.32%
2.3 Liquidity
PHIA has a Current Ratio of 1.32. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
PHIA has a Current ratio of 1.32. This is comparable to the rest of the industry: PHIA outperforms 41.18% of its industry peers.
PHIA has a Quick Ratio of 1.32. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
PHIA has a Quick ratio of 0.86. This is in the lower half of the industry: PHIA underperforms 64.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.15%, which is quite good.
PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -1.43%.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
3.2 Future
Based on estimates for the next years, PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.28% on average per year.
Based on estimates for the next years, PHIA will show a small growth in Revenue. The Revenue will grow by 3.00% on average per year.
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y10.28%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 17.31, which indicates a rather expensive current valuation of PHIA.
Based on the Price/Earnings ratio, PHIA is valued cheaper than 91.18% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.19. PHIA is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 16.78, PHIA is valued correctly.
Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than 70.59% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.92, PHIA is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.31 | ||
| Fwd PE | 16.78 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHIA indicates a somewhat cheap valuation: PHIA is cheaper than 70.59% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as PHIA.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.68 | ||
| EV/EBITDA | 13.29 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.98
PEG (5Y)N/A
EPS Next 2Y4.98%
EPS Next 3Y7.73%
5. Dividend
5.1 Amount
No dividends for PHIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMS:PHIA (1/12/2026, 5:36:15 PM)
25.62
+0.19 (+0.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners44.83%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap24.67B
Revenue(TTM)17.78B
Net Income(TTM)165.00M
Analysts72.14
Price Target27.59 (7.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP199.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.57%
Min EPS beat(2)14.1%
Max EPS beat(2)31.04%
EPS beat(4)3
Avg EPS beat(4)13.85%
Min EPS beat(4)-11.97%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-0.89%
EPS beat(12)6
Avg EPS beat(12)18.79%
EPS beat(16)6
Avg EPS beat(16)4.51%
Revenue beat(2)0
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-1.97%
Revenue beat(4)0
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-3.04%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.43%
Revenue beat(12)2
Avg Revenue beat(12)-1.64%
Revenue beat(16)2
Avg Revenue beat(16)-1.76%
PT rev (1m)-0.21%
PT rev (3m)1.12%
EPS NQ rev (1m)1.31%
EPS NQ rev (3m)3.65%
EPS NY rev (1m)0.43%
EPS NY rev (3m)3.91%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-0.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.31 | ||
| Fwd PE | 16.78 | ||
| P/S | 1.39 | ||
| P/FCF | 42.68 | ||
| P/OCF | 20.11 | ||
| P/B | 2.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.29 |
EPS(TTM)1.48
EY5.78%
EPS(NY)1.53
Fwd EY5.96%
FCF(TTM)0.6
FCFY2.34%
OCF(TTM)1.27
OCFY4.97%
SpS18.47
BVpS10.96
TBVpS-1.42
PEG (NY)3.98
PEG (5Y)N/A
Graham Number19.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.63% | ||
| ROE | 1.56% | ||
| ROCE | 5.61% | ||
| ROIC | 4.21% | ||
| ROICexc | 4.21% | ||
| ROICexgc | 11% | ||
| OM | 6.1% | ||
| PM (TTM) | 0.93% | ||
| GM | 43.49% | ||
| FCFM | 3.25% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-ScoreN/A
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 14.51 | ||
| Debt/EBITDA | 2.93 | ||
| Cap/Depr | 46.69% | ||
| Cap/Sales | 3.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 49.6% | ||
| Profit Quality | 350.3% | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 2.01 |
F-ScoreN/A
WACC6.32%
ROIC/WACC0.67
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y10.28%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%
EBIT growth 1Y712.43%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.95%
EBIT Next 3Y19.49%
EBIT Next 5Y15.13%
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NV / PHIA.AS FAQ
Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?
ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.
What is the valuation status of KONINKLIJKE PHILIPS NV (PHIA.AS) stock?
ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NV?
KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 2 / 10.
How financially healthy is KONINKLIJKE PHILIPS NV?
The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 3 / 10.
Can you provide the dividend sustainability for PHIA stock?
The dividend rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 0 / 10 and the dividend payout ratio is 199.39%.